- Home
- RMCF vs ASBP Comparison
RMCF vs ASBP Comparison
Compare RMCF & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RMCF | ASBP |
|---|---|---|
| Founded | 1981 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.9M | 12.4M |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RMCF | ASBP |
|---|---|---|
| Price | $0.82 | $8.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 29.4K | ★ 34.4K |
| Earning Date | 06-16-2026 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.88 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $30,432,352.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.66 | $0.05 |
| 52 Week High | $2.99 | $9.50 |
Technical Indicators
Market Signals| Indicator | RMCF | ASBP |
|---|---|---|
| Relative Strength Index (RSI) | 36.98 | 50.02 |
| Support Level | $0.66 | $7.80 |
| Resistance Level | $1.19 | $9.50 |
| Average True Range (ATR) | 0.04 | 0.59 |
| MACD | -0.00 | -0.10 |
| Stochastic Oscillator | 0.00 | 31.46 |
Price Performance
Historical ComparisonAbout RMCF Rocky Mountain Chocolate Factory Inc.
Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The company prepares numerous products, including caramel apples in the store. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, and Others. The company derives maximum revenue through manufacturing activities. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.
About ASBP Aspire Biopharma Holdings Inc.
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.